Diabetic women recovering from the aggressive HER2-positive form of cancer double the risk of recurrence if they take insulin. Now a Phase III trial led by scientists at Jerusalem’s Hadassah Hospital has shown that the anti-diabetic treatment metformin can prevent recurrence.

http://www.hadassah.org/news-stories/new-study-led-by-hadassah.html